ECCT Pharmaceutical Committee aims to deliver science and most innovative medications to patients in Taiwan. To help keep Taiwan healthy and prosperous, the committee partners with Taiwan government and healthcare professionals.
To support timely patient access to new drugs and promote a friendly investment environment, the committee mainly advocates on:
- Drug pricing policies: securing budget for new drugs and a reasonable price adjustment
- Adopting the best international practice such as Parallel Review to accelerate the regulatory timeline
The committee also pays attention to Taiwan's healthcare policies to foster the sustainability of Taiwan’s healthcare system as a world-class system.
